CfDNA could differentiate primary lung cancer from healthy individuals with a high sensitivity and specificity.
Sensitivity could not be improved according to the grouping factors.
Specificity was near to 90% when we unified the sample condition, detection method and reference gene.
Combination of cfDNA quantification with other tumor markers would be the future directions.